Weight loss medications and pregnancy are an underexplored area, but recent research and guidelines from drug manufacturers reveal some important facts about GLP-1 medications and pregnancy
Pavani, R
Preclinical studies in obese animal models further indicate that AOD 9604 enhances lipolytic activity within adipose tissue, with preferential effects observed in metabolically dysregulated fat cells [2]
The APRN assessment at this stage determines whether additional support is indicated
Typical Beginner Dosage 2040 mcg per day , administered once daily Injected subcutaneously (SQ) or intramuscularly (IM) Best injected post-workout on training days for maximum uptake Cycle length: 46 weeks , followed by equal time off Higher doses (50100 mcg) are used by advanced users but increase the risk of insulin resistance and IGF-related side effects
Examples licensed and available in the UK include semaglutide (Ozempic for injection, Rybelsus tablets), dulaglutide (Trulicity), liraglutide (Victoza), exenatide (Byetta), and lixisenatide (Lyxumia)